For research use only. Not for therapeutic Use.
I-BET726(Cat No.:I001715)is a potent and selective inhibitor of bromodomain and extra-terminal (BET) proteins, which are critical regulators of gene expression involved in various cellular processes, including inflammation and cancer. By targeting BET proteins, I-BET726 disrupts their interaction with acetylated histones, leading to the suppression of oncogenic transcription programs. This compound has demonstrated efficacy in preclinical studies, showing potential for treating hematological malignancies and solid tumors. I-BET726’s unique mechanism of action makes it a promising candidate for developing targeted therapies aimed at cancers driven by aberrant BET protein activity.
Catalog Number | I001715 |
CAS Number | 1446144-04-2 |
Synonyms | (S)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetamide |
Molecular Formula | C₁₉H₁₈ClN₅OS |
Purity | ≥95% |
Target | Bromodomain |
Solubility | in DMSO > 10 mM |
Storage | 2-8°C |
IC50 | 37 nM |
IUPAC Name | 2-[(9S)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-9-yl]acetamide |
InChI | InChI=1S/C19H18ClN5OS/c1-9-10(2)27-19-16(9)17(12-4-6-13(20)7-5-12)22-14(8-15(21)26)18-24-23-11(3)25(18)19/h4-7,14H,8H2,1-3H3,(H2,21,26)/t14-/m0/s1 |
InChIKey | QECMENZMDBOLDR-AWEZNQCLSA-N |
SMILES | CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)N)C4=CC=C(C=C4)Cl)C |
Reference | <p style=/line-height:25px/> |